Literature DB >> 14973180

Diurnal fluctuation of leukocyte G6PD activity. A possible explanation for the normal neutrophil bactericidal activity and the low incidence of pyogenic infections in patients with severe G6PD deficiency in Israel.

Baruch Wolach1, Meir Ashkenazi, Rami Grossmann, Ronit Gavrieli, Ziva Friedman, Nava Bashan, Dirk Roos.   

Abstract

Acute hemolytic anemia associated with red blood cell (RBC) glucose-6-phosphate dehydrogenase (G6PD) deficiency is commonly encountered in the Mediterranean basin. Nevertheless, concomitant clinical evidence of white blood cell G6PD deficiency is extremely rare in Israel. This study sought to assess simultaneously levels of G6PD activity in polymorphonuclear leukocytes (PMN) and in red blood cells (RBC) of patients with G6PD deficiency, including full-term newborn infants. In PMN, the correlation between G6PD activity, hexose monophosphate shunt activity, and superoxide anion release was evaluated. In G6PD-deficient patients, a parallel and significantly decreased G6PD activity was found in neutrophils (range of activity 0-4.5 IU/10(6) PMN) and erythrocytes (range of activity 0-1.8 IU/g Hb), compared with healthy controls (5-23 IU/10(6) PMN and 2.4-6.4 IU/g Hb, respectively). A positive correlation was found in PMN between the levels of G6PD activity, hexose monophosphate (HMP) shunt activity, and superoxide anion release (p < 0.01). Nevertheless, all patients' bactericidal activity of neutrophils remained in the range of healthy controls. Although many episodes of acute hemolytic anemia were recorded, no increased incidence of pyogenic infections was observed in any group of patients investigated. Neutrophil and erythrocyte G6PD levels were re-assessed in some of these patients several times a day. A significant diurnal fluctuation of the enzyme activity was found. It is speculated that the patients produce fluctuating daily quantities of NADPH, sufficient to initiate the neutrophil respiratory burst and to achieve normal bactericidal activity, necessary to prevent the development of microbial infections.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14973180     DOI: 10.1203/01.PDR.0000120680.47846.47

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  7 in total

1.  Lessons learned from phagocytic function studies in a large cohort of patients with recurrent infections.

Authors:  Baruch Wolach; Ronit Gavrieli; Dirk Roos; Sivan Berger-Achituv
Journal:  J Clin Immunol       Date:  2011-12-30       Impact factor: 8.317

Review 2.  The Controversial Role of Glucose-6-Phosphate Dehydrogenase Deficiency on Cardiovascular Disease: A Narrative Review.

Authors:  Maria Pina Dore; Guido Parodi; Michele Portoghese; Giovanni Mario Pes
Journal:  Oxid Med Cell Longev       Date:  2021-04-29       Impact factor: 6.543

3.  Glucose-6-phosphate dehydrogenase deficiency (G6PD) as a risk factor of male neonatal sepsis.

Authors:  Z Rostami-Far; K Ghadiri; M Rostami-Far; F Shaveisi-Zadeh; A Amiri; B Rahimian Zarif
Journal:  J Med Life       Date:  2016 Jan-Mar

Review 4.  Metabolic Insight of Neutrophils in Health and Disease.

Authors:  Sachin Kumar; Madhu Dikshit
Journal:  Front Immunol       Date:  2019-09-20       Impact factor: 7.561

Review 5.  Physiological and Pathophysiological Roles of Metabolic Pathways for NET Formation and Other Neutrophil Functions.

Authors:  Darko Stojkov; Lea Gigon; Shuang Peng; Robert Lukowski; Peter Ruth; Alexander Karaulov; Albert Rizvanov; Nickolai A Barlev; Shida Yousefi; Hans-Uwe Simon
Journal:  Front Immunol       Date:  2022-02-09       Impact factor: 7.561

6.  Glucose-6-phosphate dehydrogenase (G6PD)-deficient epithelial cells are less tolerant to infection by Staphylococcus aureus.

Authors:  Yi-Ting Hsieh; Mei-Hui Lin; Hung-Yao Ho; Lei-Chin Chen; Chien-Cheng Chen; Jwu-Ching Shu
Journal:  PLoS One       Date:  2013-11-04       Impact factor: 3.240

7.  G6PD Deficiency Does Not Enhance Susceptibility for Acquiring Helicobacter pylori Infection in Sardinian Patients.

Authors:  Maria Pina Dore; Giuseppina Marras; Chiara Rocchi; Sara Soro; Giovanni Mario Pes
Journal:  PLoS One       Date:  2016-07-28       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.